Evidence map›Paper›PMID 35419920›Full record

ArticlePediatric diabetes2022

Viral infection-related gene upregulation in monocytes in children with signs of β-cell autoimmunity.

Milla Valta, Masahito Yoshihara, Elisabet Einarsdottir, Sirpa Pahkuri, Sini Ezer, Shintaro Katayama, Mikael Knip, Riitta Veijola, Jorma Toppari, Jorma Ilonen and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Pediatric diabetes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Milla ValtaImmunogenetics Laboratory, Institute of Biomedicine, University of Turku, Turku, Finland.ORCID 0000-0001-6674-4182
Masahito YoshiharaDepartment of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden.ORCID 0000-0002-8915-9282
Elisabet EinarsdottirScience for Life Laboratory, Department of Gene Technology, KTH-Royal Institute of Technology, Solna, Sweden.
Sirpa PahkuriImmunogenetics Laboratory, Institute of Biomedicine, University of Turku, Turku, Finland.
Sini EzerStem Cells and Metabolism Research Program, University of Helsinki, and Folkhälsan Research Center, Helsinki, Finland.
Shintaro KatayamaDepartment of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden.
Mikael KnipPediatric Research Center, Children's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.ORCID 0000-0003-0474-0033
Riitta VeijolaDepartment of Pediatrics, PEDEGO Research Unit, MRC Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland.ORCID 0000-0002-6557-270X
Jorma ToppariInstitute of Biomedicine, Research Centre for Integrative Physiology and Pharmacology, University of Turku, Turku, Finland.
Jorma IlonenImmunogenetics Laboratory, Institute of Biomedicine, University of Turku, Turku, Finland.
Juha KereDepartment of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden.
Johanna LempainenImmunogenetics Laboratory, Institute of Biomedicine, University of Turku, Turku, Finland.
University of Turku · FIUniversity of Helsinki · FIKarolinska Institutet · SEOulu University Hospital · FIScience for Life Laboratory · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe pathogenesis of type 1 diabetes (T1D) is associated with genetic predisposition and immunological changes during presymptomatic disease. Differences in immune cell subset numbers and phenotypes between T1D patients and healthy controls have been described; however, the role and function of these changes in the pathogenesis is still unclear. Here we aimed to analyze the transcriptomic landscapes of peripheral blood mononuclear cells (PBMCs) during presymptomatic disease.

methodsTranscriptomic differences in PBMCs were compared between cases positive for islet autoantibodies and autoantibody negative controls (9 case-control pairs) and further in monocytes and lymphocytes separately in autoantibody positive subjects and control subjects (25 case-control pairs).

resultsNo significant differential expression was found in either data set. However, when gene set enrichment analysis was performed, the gene sets "defence response to virus" (FDR <0.001, ranking 2), "response to virus" (FDR <0.001, ranking 3) and "response to type I interferon" (FDR = 0.002, ranking 12) were enriched in the upregulated genes among PBMCs in cases. Upon further analysis, this was also seen in monocytes in cases (FDR = 0.01, ranking 2; FDR = 0.04, ranking 3 and FDR = 0.02, ranking 1, respectively) but not in lymphocytes.

conclusionGene set enrichment analysis of children with T1D-associated autoimmunity revealed changes in pathways relevant for virus infection in PBMCs, particularly in monocytes. Virus infections have been repeatedly implicated in the pathogenesis of T1D. These results support the viral hypothesis by suggesting altered immune activation of viral immune pathways in monocytes during diabetes.

Indexed as

Diabetes Mellitus, Type 1Virus DiseasesAsymptomatic DiseasesAutoantibodiesAutoimmunityHumansLeukocytes, MononuclearMonocytesUp-RegulationAutoantibodiesmonocytestype 1 diabetesviral responseβ-cell autoimmunity

Identifiers

PMID35419920
PMCPMC9545759
OpenAlexW4224054973

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.